Research output per year
Research output per year
Personal profile
Biography
My research focuses on thymus sero-immunology, since I believe that this is one of the most important yet understudied fields in immunology. My long-term research interest involves understanding thymus function in maintaining health and after thymic injury, as due to (cancer)therapies, infections, or aging. In the short-term, I specifically aim to better understand the role of the human thymic secretome in immunology and how this underevaluated thymus function affects thymopoiesis recovery after hematopoietic cell transplantation. Trained as an applied immunologist (Ph.D. dissertation, SMBWO-certification) with both laboratory and computational skills, I am a translational researcher uniquely equipped to investigate thymus immunology with a vision for clinical impact of my research.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior
Jansen, S. A., Cutilli, A., de Koning, C., van Hoesel, M., Frederiks, C. L., Saiz Sierra, L., Nierkens, S., Mokry, M., Nieuwenhuis, E. E. S., Hanash, A. M., Mocholi, E., Coffer, P. J. & Lindemans, C. A., 21 Jun 2024, In: iScience. 27, 6, p. 1-19 19 p., 110072.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Prophylactic use of liposomal amphotericin B in children and adolescents undergoing allogeneic hematopoietic cell transplantation: A 10-years single center experience
Rotte, L. G. Y., de Koning, C. C. H., Loeffen, Y. G. T., Bierings, M. B., Jan Boelens, J., Lindemans, C. A. & Wolfs, T. F. W., Dec 2024, In: EJC Paediatric Oncology. 4, 5 p., 100175.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Chemotherapy-induced intestinal injury promotes Galectin-9-driven modulation of T cell function
Jansen, S. A., Cutilli, A., de Koning, C., van Hoesel, M., Sierra, L. S., Nierkens, S., Mokry, M., Nieuwenhuis, E. E. S., Hanash, A. M., Mocholi, E., Coffer, P. J. & Lindemans, C. A., 30 Apr 2023, BioRxiv, (bioRxiv).Research output: Working paper › Preprint › Academic
-
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis
Troullioud Lucas, A. G., Lindemans, C. A., Bhoopalan, S. V., Dandis, R., Prockop, S. E., Naik, S., Keerthi, D., de Koning, C., Sharma, A., Nierkens, S. & Boelens, J. J., Sept 2023, In: Cytotherapy. 25, 9, p. 977-985 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
Versluijs, A. B., de Koning, C. C. H., Lankester, A. C., Nierkens, S., Kollen, W. J., Bresters, D., Lindemans, C. A., Boelens, J. J. & Bierings, M., 22 Mar 2022, In: Blood Advances. 6, 6, p. 1719-1730 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)2 Downloads (Pure)